Immune thrombocytopenia (ITP) – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030
Immune thrombocytopenia (ITP) – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030 Description: Indication name: Immune thrombocytopenia (ITP) Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by a blood abnormality called thrombocytopenia, a shortage of blood cells called platelets needed for normal blood clotting. Affected individuals can develop red or purple spots on the skin caused by bleeding just under the skin's surface. Etiology- The genetic cause of immune thrombocytopenia is unclear. This condition occurs when the body's immune system malfunctions and attacks the body's tissues and organs (autoimmunity). Epidemiology- The incidence of ITP among adults in the USA is estimated to be 3.3 per 100,000 adults/year. The prevalence is 9.5 cases per 100,000. The annual prevalence is estimated at 5.3 per 100,000 among children; because children with ITP usually recover, the number of ...